At Sensei Biotherapeutics, we develop conditionally active antibodies that are designed to function selectively in the tumor microenvironment to tilt the power of the immune system against cancer. The Sensei team brings together leaders with deep expertise in our core disciplines, along with a highly accomplished team of life science business leaders.

Leadership Team


John K. Celebi, MBA

President & Chief Executive Officer


Erin Colgan

Chief Financial Officer


Patrick Gallagher, MBA, MPH

Chief Business Officer

Edward for web Aug 2022

Edward van der Horst, Ph.D.

Chief Scientific Officer

Chris Gerry 1 17 23

Christopher Gerry, J.D.

Vice President, General Counsel

Board of Directors

William Ringo, MBA

Board Chair

Samuel Broder, M.D.

John K. Celebi, MBA

Jessie English, Ph.D.

Bob Holmen, J.D.

Kristian Humer, MBA

James Peyer, Ph.D.

Tom Ricks, MBA

Deneen Vojta, M.D.

Immuno-Oncology Advisory Board

Alain Algazi, M.D.

Maura Gillison, M.D., Ph.D.

Sara Pai, M.D., Ph.D.

Robert Schreiber, Ph.D.

Daniel H. Sterman, M.D.

Richard Ulevitch, Ph.D.

HQ: 1405 Research Blvd, Suite 125,
Rockville, MD 20850

MA: 22 Boston Wharf Rd, 7th Floor,
Boston, MA 02210